AstraZeneca completes two commercial rights deals, payments included in Q2 2017
AstraZeneca on Monday reported closing two different agreements for certain commercial rights for its drugs, in Europe and worldwide...
Subscribe to Read More..
Your comment will be posted after it is approved.
Leave a Reply.
Create a free website